We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Integrated Syringe System Protects Highly Sensitive Compounds

By HospiMedica International staff writers
Posted on 26 Jul 2015
Print article
Image: The Vetter-Ject syringe closure system for filling highly sensitive compounds (Photo courtesy of Vetter).
Image: The Vetter-Ject syringe closure system for filling highly sensitive compounds (Photo courtesy of Vetter).
A novel closure system for prefilled syringes comes with a ready-to-use integrated needle, offering safer use of highly-sensitive compounds such as biologics.

The Vetter-Ject syringe closure system consists of a needle hub, an integrated staked needle, and a needle shield with a tamper-evident closure system that visibly and permanently reveals attempts at opening it to the naked eye; when the needle shield is removed, the plastic bridges are broken. Complete sterile fill and final packaging of the syringe system are provided as part of the primary packaging service, including a wide range of optional stoppers, trays, and plunger rod assemblies. The company can also provide complete auto-injector assembly.

The Vetter-Ject is manufactured by means of a two-component injection molding process based on polypropylene and a thermoplastic elastomer. An individually adaptable siliconization process means less silicon oil than commonly used is necessary for coating the glass barrel, making it particularly suitable for silicon-sensitive drug products, as the amount of silicon used and the related particle load can be reduced by up to 80%, when compared to the standard siliconization process applied to conventional syringe systems. The Vetter-Ject syringe closure system is a product of Vetter (Ravensburg, Germany).

“Vetter-Ject is ready-to-use with an integrated needle that is simple to handle and user-friendly. Our patented syringe closure system offers pharmaceutical and biotech companies more options for filling highly sensitive parenteral drugs,” said Tilman Roedle, director of packaging development at Vetter. “Patients and qualified medical personnel now have the advantage of the system's easy handling and high standards for product safety and integrity.”

The siliconization of glass vials has three advantages. It minimizes the interactions between the product and container; it prevents high viscosity products from sticking to the internal surface of the vials, giving the glass bottle a prefect transparency; and due to its hydrophobic properties, the silicone coating ensures a higher restitution rate of the product. The resistance of the silicone coating depends on the chemical structure of the product formulation, as well as its dissolving power on silicone.

Related Links:

Vetter


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Baby Warmer
THERMOCARE Convenience

Print article

Channels

Surgical Techniques

view channel
Image: ‘Wraparound’ implants represent a new approach to treating spinal cord injuries (Photo courtesy of 123RF)

Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries

The spinal cord functions as a vital conduit, transmitting nerve impulses to and from the brain, much like a highway. When the spinal cord is damaged, this flow of information is disrupted, leading to... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more